A review of contamination control in pharmaceutical industry in the current SARS-CoV-2 pandemic context

ABSTRACT

The objective of this paper is to assess whether the contamination control measures already being applied in the pharmaceutical industrial production are efficient enough in the context of a viral pandemic, such as the SARS-CoV-2 pandemic of 2020-2021. The questions that must be asked are linked to the efficacy of already existing virucides against the newly discovered viral strand and whether there is a need for supplementary precautions in regards with the workers that have direct contact with the finished product or operate the machines that package the finished goods. The discussion will revolve around the efficacy of current protocols of disinfection, the need for workers' continuous and rigorous training, and the transparency in which quality control must be implemented, as to ensure the public's trust in the industrial process.